The current URGN market cap is 511.83M. The company's latest EPS is USD -3.2174 and P/E is -4.65.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 16.1M | 18.09M | 17.19M | 21.14M | 20.85M |
Operating Income | -18.09M | -20.28M | -22.05M | -15.38M | -13.5M |
Net Income | -25.83M | -28.87M | -30.21M | -24.14M | -21.88M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.13M | 18k | 11.8M | 48.04M | 64.36M |
Operating Income | -77.18M | -109.48M | -126.74M | -92.29M | -79.04M |
Net Income | -75.66M | -105.15M | -128.48M | -110.82M | -109.78M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 128.47M | 135.62M | 112.95M | 95.36M | 193.63M |
Total Liabilities | 191.76M | 224.98M | 229.51M | 233.8M | 235.63M |
Total Equity | -63.29M | -89.36M | -116.55M | -138.43M | -41.99M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 103.56M | 202.39M | 122.01M | 119.75M | 135.62M |
Total Liabilities | 13.47M | 22.09M | 25.65M | 111.33M | 224.98M |
Total Equity | 90.09M | 180.3M | 96.36M | 8.41M | -89.36M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -65.81M | -87.56M | -25.81M | -46.08M | -63.38M |
Investing | -22.05M | 1.06M | 6.27M | 9.99M | 10.39M |
Financing | 71.77M | 97.13M | 671k | 814k | 116.89M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -37.33M | -71.02M | -105.89M | -84.89M | -87.56M |
Investing | 35.29M | -145.59M | 93.24M | 4.07M | 1.06M |
Financing | 66.42M | 165.25M | 16.53M | 72.32M | 97.13M |
Market Cap | 511.83M |
Price to Earnings Ratio | -4.65 |
Price to Sales Ratio | 7.94 |
Price to Cash Ratio | 9.22 |
Price to Book Ratio | -5.72 |
Dividend Yield | - |
Shares Outstanding | 34.12M |
Average Volume (1 week) | 837.75k |
Average Volume (1 Month) | 434.04k |
52 Week Change | 84.96% |
52 Week High | 24.13 |
52 Week Low | 7.79 |
Spread (Intraday) | 1.16 (7.37%) |
Company Name | UroGen Pharma Ltd |
Address |
9 hataasiya st ra'anana, center 4365007 |
Website | https://www.urogen.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.